| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,784 |
1,133 |
$812K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,164 |
2,221 |
$564K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,420 |
3,679 |
$456K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,852 |
2,380 |
$430K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,957 |
1,519 |
$393K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,344 |
923 |
$237K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
992 |
862 |
$135K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,521 |
1,312 |
$114K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
329 |
279 |
$110K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
271 |
220 |
$80K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
680 |
528 |
$75K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
692 |
575 |
$45K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,393 |
1,178 |
$40K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
471 |
384 |
$39K |
| 80053 |
Comprehensive metabolic panel |
5,517 |
4,400 |
$39K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,806 |
5,184 |
$33K |
| 70450 |
Computed tomography, head or brain; without contrast material |
123 |
102 |
$29K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
176 |
155 |
$28K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
655 |
571 |
$27K |
| 71046 |
Radiologic examination, chest; 2 views |
1,295 |
931 |
$25K |
| 80061 |
Lipid panel |
2,159 |
1,947 |
$22K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,757 |
1,543 |
$22K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,851 |
423 |
$21K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,548 |
417 |
$20K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
300 |
230 |
$19K |
| 99215 |
Prolong outpt/office vis |
104 |
76 |
$18K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,867 |
2,277 |
$17K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
679 |
610 |
$17K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,696 |
2,107 |
$12K |
| 84484 |
|
1,997 |
1,224 |
$10K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
909 |
787 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,143 |
1,053 |
$8K |
| 81001 |
|
3,542 |
2,820 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
63 |
47 |
$8K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
53 |
48 |
$6K |
| 80050 |
General health panel |
522 |
462 |
$6K |
| 82728 |
|
474 |
429 |
$6K |
| 87634 |
|
149 |
114 |
$6K |
| 83690 |
|
1,276 |
1,020 |
$6K |
| 81025 |
|
594 |
516 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
157 |
145 |
$4K |
| 85027 |
|
850 |
694 |
$4K |
| 85610 |
|
1,372 |
885 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
553 |
472 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
37 |
22 |
$3K |
| 87631 |
|
27 |
25 |
$3K |
| 83605 |
|
543 |
390 |
$3K |
| 83880 |
|
136 |
114 |
$2K |
| 83735 |
|
643 |
502 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
1,012 |
774 |
$2K |
| 84153 |
|
147 |
136 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
9,573 |
6,903 |
$2K |
| 86803 |
|
176 |
157 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,684 |
1,290 |
$2K |
| 86140 |
|
653 |
549 |
$2K |
| 84439 |
|
252 |
222 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
141 |
91 |
$2K |
| 73562 |
|
16 |
13 |
$1K |
| 85379 |
|
237 |
196 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
359 |
231 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
18 |
17 |
$860.54 |
| 83550 |
|
109 |
98 |
$830.29 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
803 |
553 |
$763.13 |
| 73030 |
|
17 |
12 |
$748.00 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
50 |
48 |
$695.85 |
| 97035 |
|
203 |
41 |
$660.33 |
| 83655 |
|
46 |
42 |
$535.89 |
| 82150 |
|
113 |
96 |
$524.14 |
| 83540 |
|
80 |
73 |
$487.99 |
| 97161 |
|
25 |
17 |
$487.01 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
12 |
$486.12 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
16 |
13 |
$463.33 |
| 85652 |
|
209 |
178 |
$407.34 |
| 87040 |
|
134 |
67 |
$389.51 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
25 |
12 |
$388.13 |
| 81003 |
|
132 |
107 |
$313.20 |
| 82570 |
|
63 |
61 |
$306.04 |
| 88142 |
|
17 |
14 |
$267.16 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
990 |
751 |
$258.35 |
| 84145 |
|
31 |
28 |
$255.70 |
| 84702 |
|
19 |
12 |
$254.76 |
| 82043 |
|
43 |
42 |
$245.64 |
| 80306 |
|
20 |
13 |
$202.28 |
| 82550 |
|
81 |
41 |
$201.62 |
| 96376 |
|
30 |
14 |
$197.09 |
| 85018 |
|
79 |
71 |
$160.85 |
| 82962 |
|
78 |
37 |
$137.48 |
| 36592 |
|
355 |
293 |
$116.49 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
173 |
147 |
$84.85 |
| 85730 |
|
33 |
25 |
$80.16 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,484 |
714 |
$15.45 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
894 |
639 |
$9.53 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
484 |
342 |
$6.96 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
200 |
103 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
28 |
14 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
17 |
14 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
63 |
55 |
$0.00 |
| A9270 |
Non-covered item or service |
172 |
121 |
$0.00 |
| 3044F |
|
13 |
13 |
$0.00 |
| J3490 |
Unclassified drugs |
15 |
12 |
$0.00 |